Share on StockTwits

Marrone Bio Innovations (NASDAQ:MBII) was downgraded by stock analysts at Piper Jaffray to a “neutral” rating in a report issued on Friday.

Marrone Bio Innovations (NASDAQ:MBII) opened at 9.54 on Friday. Marrone Bio Innovations has a 1-year low of $8.21 and a 1-year high of $20.00. The stock has a 50-day moving average of $10.33 and a 200-day moving average of $12.41. The company’s market cap is $225.2 million.

Marrone Bio Innovations (NASDAQ:MBII) last announced its earnings results on Tuesday, May 13th. The company reported ($0.52) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.38) by $0.14. The company had revenue of $2.80 million for the quarter, compared to the consensus estimate of $4.63 million. On average, analysts predict that Marrone Bio Innovations will post $-1.67 earnings per share for the current fiscal year.

A number of other firms have also recently commented on MBII. Analysts at Robert W. Baird initiated coverage on shares of Marrone Bio Innovations in a research note on Monday, June 30th. They set an “outperform” rating and a $15.00 price target on the stock. Analysts at Jefferies Group cut their price target on shares of Marrone Bio Innovations from $23.00 to $18.00 in a research note on Monday, June 9th. They now have a “buy” rating on the stock. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $18.00.

Marrone Bio Innovations, Inc is a provider of bio-based pest management and plant health products. Bio-based products are consists of naturally occurring microorganisms, such as bacteria and fungi, and plant extracts.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.